Skip to main content
. 2020 Mar 25;12(4):778. doi: 10.3390/cancers12040778

Figure 4.

Figure 4

In vitro treatment with Verteporfin reduces migration and invasion capabilities in GB-d1 and G-415 cell lines. (A) Reduced expression of YAP1 and phospho-YAP in GB-d1 and G-415 cells treated with increasing concentrations of Verteporfin (VP). (B) Relative migration of GB-d1 and G-415. Magnification: 20×. (C) Relative invasion of GB-d1 and G-415. Results are represented as Mean ± SD from 3 independent experiments (* p < 0.05, ** p < 0.01 and ns: no significant by one-sample t-test). Magnification: 20×.